Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists. Thromb Haemost. 2017 04 03; 117(4):784-793.
View in:
PubMed
subject areas
Aged
Aged
Anticoagulants
Anticoagulants
Blood Coagulation
Blood Coagulation
Decision Support Techniques
Decision Support Techniques
Double-Blind Method
Double-Blind Method
Factor Xa Inhibitors
Factor Xa Inhibitors
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
International Normalized Ratio
International Normalized Ratio
Male
Male
Middle Aged
Middle Aged
Predictive Value of Tests
Predictive Value of Tests
Pyridines
Pyridines
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Thiazoles
Thiazoles
Treatment Outcome
Treatment Outcome
Venous Thromboembolism
Venous Thromboembolism
Vitamin K
Vitamin K
Warfarin
Warfarin
authors with profiles
Gary E Raskob